2023-11-09 18:09:51
From this Thursday quadrivalent dengue vaccine It is now available in Argentina, but only privately. This launch comes following new cases of this viral disease transmitted by el mosquito Aedes aegypti. The records show that there is clear persistence of indigenous cases and cases under investigation, especially in the northeastern region of Argentina.
In fact, as reflected in the latest report from the National Epidemiological Bulletin in its 43rd week, they are already being counted in Argentina 132,237 cases of dengue since January: 123,538 indigenous, 1,584 imported and 7,151 under investigation.
confirmed cases they grew from 77 to 118 in a weekand probable cases from 269 to 298, of which 270 belong only to the northeastern region of Argentinaone of the areas that is historically most affected by dengue: 255 in Chaco, 13 in Corrientes and 2 in Formosa.
That is why the Qdenga vaccine, which is developed Takeda for more than 10 years and was approved by the National Administration of Medicines, Food and Medical Technology (ANMAT) in April of this year, represents an important advance to stop the growth of cases in the face of a new summer season in Argentina, although specialists highlight the importance of scrapping as a prevention measure.
This quadrivalent vaccine is now available in private vaccination centers and soon in pharmacies, and must be applied with prescription.
The details were presented by Takeda, the Japanese laboratory that produces it, in a meeting with the press this Thursday at noon. In a statement, he noted that “the vaccine is private indication and its cost is similar or even lower than that of other new or recent vaccines already available in the private market, however, it is possible that the different prepaid and social works offer their members discounts that may range from 40%, 60 % or even more.”
According to reports, the only one that currently has coverage is OSDE, the 40% discount. And the government of Salta is advancing an agreement to buy 300,000 doses, which would be administered free of charge, he told Clarion Ramiro Bordón, director of the laboratory’s Vaccine Business Unit.
In Stamboulian, one of the vaccination centers that is already administering it, the vaccine costs $38,000 per dose and $22,800 for OSDE members. The vaccine is applied with a prescription “because a medical prescription is needed as it is in prepaid and social works,” they clarified from Takeda.
How the dengue vaccine is applied
As explained Clarion Previously, this vaccine must be applied in two doses with an interval of three months. Immunity is achieved 10 days following the application of the second dose, although it is already established from the application of the first.
The same can be applied from 4 years old and without age limit, regardless of whether you have had dengue or not and without the need for a confirmatory blood test. But it is contraindicated for pregnant women, breastfeeding women and immunosuppressed people.
1699553726
#costs #key #requirement #receive